Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- US stock futures rise as investors assess Democrats' midterm sweep
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $6.71 --0%
EPS Growth %: -8.3%
Financial Fact:
Loss per common share - basic and diluted: -0.14
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: -8.3%
Financial Fact:
Loss per common share - basic and diluted: -0.14
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Timken (TKR) Tops Q3 EPS by 17c, Offers FY26 EPS Guidance
- Clear Secure, Inc. (YOU) Tops Q3 EPS by 8c; Offers Guidance
- Materion Corp. (MTRN) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
